Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome

BACKGROUND: Cytokine release syndrome (CRS) is a systemic inflammatory response characterized by the overexpression of inflammatory genes. Controlling CRS is essential for improving the therapeutic effects of chimeric antigen receptor (CAR) engineered T cells. However, current treatment options are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ye, Li, Chong, Bian, Huifang, Qian, Wei, Jin, Kairui, Xu, Tingting, Guo, Xiaomao, Lu, Xueguan, Su, Fengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780220/
https://www.ncbi.nlm.nih.gov/pubmed/33397398
http://dx.doi.org/10.1186/s12943-020-01301-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780220/
https://www.ncbi.nlm.nih.gov/pubmed/33397398
http://dx.doi.org/10.1186/s12943-020-01301-7

Ejemplares similares